CHGCY:OTCMKTS
Chugai Pharmaceutical ADR
USD 19,16
arrow_downward
-0,21%(-0,040) 1D
9 Okt., 16:00:00 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CHGCY...
Open
USD 19,36
High
USD 19,43
Low
USD 18,98
Mkt. cap
10,11 bn
Avg. vol.
297,78 k
Volume
327,36 k
52-wk high
USD 34,84
52-wk low
USD 18,98
Beta
0,56
Shares outstanding
3,36 mjd
No. of employees
5 k
Open
USD 19,36
High
USD 19,43
Low
USD 18,98
Mkt. cap
10,11 bn
Avg. vol.
297,78 k
Volume
327,36 k
52-wk high
USD 34,84
52-wk low
USD 18,98
Beta
0,56
Shares outstanding
3,36 mjd
No. of employees
5 k
News stories
From web sources and news partners
ad-hoc-news.de
·
1 dag gelede
Chugai Pharmaceutical stock sits at EUR 33.94 in weekend trading
Profile
Chugai Pharmaceutical Co., Ltd. is a drug manufacturer operating in Japan. It is a subsidiary controlled by Hoffmann-La Roche, which owns 62% of the company as of 30 June 2014. The company is headquartered in Tokyo. Osamu Nagayama is the current representative director and chairman. Tatsuro Kosaka is the current representative director, president and CEO. Wikipedia
About Chugai Pharmaceutical ADR
CEOOsamu Okuda
Employees5,1 k
Founded10 Mrt. 1925
Headquarters-
SectorPharmaceutical industry
Websitechugai-pharm.co.jp